195 filings
Page 9 of 10
8-K/A
n1wa i85mbz
12 Jun 14
Financial Statements and Exhibits
12:00am
8-K/A
altm9995 ok
10 Jun 14
Financial Statements and Exhibits
12:00am
8-K
l662yss
4 Jun 14
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development
12:00am
8-K
el8tlv 4w8mv3e1
4 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
nyosgc89qqvzl2qp
4 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
x63z9
3 Jun 14
Retrophin Names Stephen Aselage President and Chief Operations Officer
12:00am
8-K
yp2age
14 May 14
Retrophin Reports First Quarter 2014 Financial Results
12:00am
8-K
tkzzhar4o3ssm
13 May 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
e5y7agsz3jzoc2zkxk
14 Apr 14
Retrophin Updates Financial Guidance for 2014 and 2015 and Provides Corporate Update
12:00am
8-K
afy4fwoi7 w4c
4 Apr 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
nfwqh71qlbdsvil rq6
3 Apr 14
Other Events
12:00am
8-K
9ttg 4lu563rsr
31 Mar 14
Retrophin Completes Acquisition of Manchester Pharmaceuticals
12:00am
8-K
a35q1wtungj7e5b8
28 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
04a 6tsr9wly8nkyi896
18 Feb 14
Retrophin Announces Agreement to Acquire Manchester Pharmaceuticals
12:00am
8-K
rd412on1f v2xuh9b6
13 Feb 14
Regulation FD Disclosure
12:00am
8-K/A
3wzyzcbxd6n
7 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
b7la6apjk7ovqc597
7 Jan 14
Entry into a Material Definitive Agreement
12:00am
8-K
5gm7 fiwxuqqzsb7dn
30 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
ka6tmr81xvpc6z
18 Dec 13
Entry into a Material Definitive Agreement
12:00am
8-K
4x7898 ov4wrps7
16 Dec 13
Retrophin Withdraws Offer for Transcept Pharmaceuticals
12:00am